Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma | Zendy

Thomas Powles | Zendy; Se Hoon Park | Zendy; Éric Voog | Zendy; Claudia Caserta | Zendy; Begoña P. Valderrama | Zendy; Howard Gurney | Zendy; Haralabos P. Kalofonos | Zendy; Siniša Radulović | Zendy; Wim Demey | Zendy; Anders Ullén | Zendy; Yohann Loriot | Zendy; Srikala S. Sridhar | Zendy; Norihiko Tsuchiya | Zendy; Evgeny Kopyltsov | Zendy; Cora N. Sternberg | Zendy; Joaquim Bellmunt | Zendy; Jeanny B. AragonChing | Zendy; Daniel P. Petrylak | Zendy; Robert J Laliberte | Zendy; Jing Wang | Zendy; Bo Huang | Zendy; Craig B. Davis | Zendy; Camilla Fowst | Zendy; Nuno Costa | Zendy; John A. Blake-Haskins | Zendy; Alessandra di Pietro | Zendy; Petros Grivas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

Author(s) -

Thomas Powles,

Se Hoon Park,

Éric Voog,

Claudia Caserta,

Begoña P. Valderrama,

Howard Gurney,

Haralabos P. Kalofonos,

Siniša Radulović,

Wim Demey,

Anders Ullén,

Yohann Loriot,

Srikala S. Sridhar,

Norihiko Tsuchiya,

Evgeny Kopyltsov,

Cora N. Sternberg,

Joaquim Bellmunt,

Jeanny B. AragonChing,

Daniel P. Petrylak,

Robert J Laliberte,

Jing Wang,

Bo Huang,

Craig B. Davis,

Camilla Fowst,

Nuno Costa,

John A. Blake-Haskins,

Alessandra di Pietro,

Petros Grivas

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2002788

Subject(s) - avelumab , urothelial carcinoma , metastatic urothelial carcinoma , chemotherapy , oncology , medicine , carcinoma , standard of care , immunotherapy , cancer , bladder cancer , pembrolizumab

Platinum-based chemotherapy is standard-of-care first-line treatment for advanced urothelial carcinoma. However, progression-free survival and overall survival are limited by chemotherapy resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research